Clinical references GLP-1RA and the possible skin ageing: A closer look at the dermatological profile of GLP-1 agonists: Ozempic face, an emerging drug-related aesthetic concern: Semaglutide Ozempic face and implications in cosmetic dermatology: Aesthetic restoration following GLP-1 agonist-induced facial volume loss: The science behind Ozempic face: Ozempic face in plastic surgery, systematic review: Treating Ozempic face, facial rejuvenation after weight loss:
Inestrosa, N
You might say, There is intriguing early research, but we dont yet have definitive evidence for this use. By doing so, you validate patient curiosity while clearly framing uncertainty
Pancreas: Insulin Secretion: Semaglutide stimulates the beta cells in the pancreas to produce more insulin in response to high blood glucose levels
By keeping food in your stomach longer, compounded semaglutide helps reduce the urge to snack or overeat, supporting consistent calorie reduction and steady, manageable weight loss
Medical supervision matters regardless of which format patients choose